Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Raltitrexed for Injection

Approval Number

国药准字H20223017

Company迅博康（海南）医药科技有限公司

Registration Date

January 18, 2022

Drug Information

Generic Name

注射用雷替曲塞

Dosage Form

注射剂

Strength

2mg

Drug Type

化学药品

Registration Date

January 18, 2022

Company Information

Applicant Company

Company Name迅博康（海南）医药科技有限公司

Company Address

海南省澄迈县老城镇高新技术产业示范区海南生态软件园孵化楼三楼301室

Manufacturing Company

Company Name广东星昊药业有限公司

Company Address

中山火炬开发区国家健康基地内健康路17号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用雷替曲塞 - NMPA 批准文号 | MedPath